B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

MET Receptor Activation

REACTOME PATHWAY
Reactome: R-HSA-68069422 genes11 compounds

The MET Receptor Activation pathway (Reactome ID: R-HSA-6806942) involves 2 genes and is affected by 11 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

HPNMET

Compounds Affecting MET Receptor Activation

#CompoundTargets HitStudies
1Crizotinib—298
2Afatinib—297
3egcg—300
4Axitinib—298
5Sorafenib—300
6Quercetin—300
7Adenosine Triphosphate—300
8sp600125—117
9Anthralin—299
10Gabexate—300
11Meclizine—121

About the MET Receptor Activation Pathway

The MET Receptor Activation pathway is catalogued in Reactome (ID: R-HSA-6806942) and involves 2 genes. In the BiohacksAI corpus, 11 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include HPN, MET.